Trials / Completed
CompletedNCT00136773
Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 332 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 21 Years – 85 Years
- Healthy volunteers
- —
Summary
Type 2 diabetes mellitus is usually associated with high blood pressure, which is a risk factor for kidney disease. Aggressive blood pressure reduction is an important strategy to protect the kidney and reduce urinary protein which develops with kidney disease. This study will evaluate the effects of amlodipine/benazepril in reducing blood pressure and urinary protein in hypertensive subjects with type 2 diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | amlodipine/benazepril |
Timeline
- Start date
- 2003-04-01
- Primary completion
- 2005-10-01
- Completion
- 2005-11-01
- First posted
- 2005-08-29
- Last updated
- 2011-03-09
Source: ClinicalTrials.gov record NCT00136773. Inclusion in this directory is not an endorsement.